Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

Biotechnology

Healthcare
$7.38 -2.78%

-$0.15 today

Market cap
$2.10B
Beta
0.71
P/E (TTM)
-7.1
EPS (TTM)
-$0.71
52W Low $1.99High $5.32

Volume 1.41M

Average 2.42M

Balance Sheet

Inspect the capital base behind the business.

Assets

$770.58M

FY 2025 · Annual

-23.6% YoY

Liabilities

$397.87M

FY 2025 · Annual

-7.7% YoY

Equity

$372.71M

FY 2025 · Annual

-35.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents551.27M632.14M574.96M322.4M216.89M
Short-term Investments00000
Net Receivables117.51M146.81M55.72M38.52M25.5M
Inventory51.56M43.15M51.4M50.08M40.5M
Other Current Assets025.8M17.83M18.15M13.37M
Total Current Assets740.04M847.9M699.91M429.15M296.25M
Property, Plant & Equipment (Net)95.43M116.59M222.65M217.03M1.22M
Goodwill152.77M283.67M326.03M159.88M129.43M
Intangible Assets117.57M216.66M220.99M194.96M151.54M
Long-term Investments011.36M8.56M00
Tax Assets808.12M765.8M000
Other Non-current Assets4.36M40.33M9.32M7.24M192.14M
Total Non-current Assets1.18B1.43B787.54M579.1M474.33M
Total Assets1.92B2.28B1.49B1.01B770.58M
Account Payables8.15M5.99M10.73M11.96M0
Short-term Debt6M5.44M5.44M5.44M5.44M
Tax Payables1.4M1.03M1M779K24.49M
Deferred Revenue12.64M3.09M3.36M3.29M0
Other Current Liabilities18.89M69.48M47.62M18.71M39.48M
Total Current Liabilities93.78M110.14M87.47M56.97M44.92M
Long-term Debt524.59M522M518.71M290.49M30.14M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities713.64M693.38M11.98M11.09M322.81M
Total Non-current Liabilities1.28B1.27B610.1M374.06M352.95M
Total Liabilities1.37B1.38B697.57M431.04M397.87M
Common Stock2.55M2.55M2.51M2.53M2.56M
Retained Earnings184.56M404.77M285.74M140.89M10.12M
Accumulated OCI0000524K
Other Stockholders Equity00000
Minority Interest229.86M360.03M373.13M251.92M160.33M
Total Equity545.36M905.24M789.88M577.21M372.71M
Total Debt575.22M585.26M610.97M376.69M35.58M
Net Debt23.95M(46.88M)36.01M54.29M(181.31M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$70.1M
Receivables$31.1M
Inventory$41.2M
Other Current$13.2M
Total Current Assets$155.7M
PP&E (Net)$142.4M
Goodwill$129.4M
Intangible Assets$138.4M
Other Non-current$37.9M
Total Non-current Assets$448.1M
Total Assets$603.7M

Analysis

Selected assets total $603.7M for Latest. The largest visible component is PP&E (Net) at $142.4M, about 23.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 4, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipOct 9, 2026

How much cash does MRVI have?

Maravai LifeSciences Holdings, Inc. (MRVI) reported $216.89M in cash and equivalents in fiscal 2025.

How much debt does MRVI carry?

Maravai LifeSciences Holdings, Inc. (MRVI) reported $35.58M of total debt, with net debt of -$181.31M.